{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:23:27Z","timestamp":1783020207868,"version":"3.54.6"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["310728\/Z\/24\/Z"],"award-info":[{"award-number":["310728\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>New adult tuberculosis (TB) vaccines are in clinical trials and may be licensed as soon as 2028. However, vaccine rollout requires addressing multiple contextual factors beyond clinical trial findings. This study explored stakeholders\u2019 perspectives on the introduction of a new TB vaccine in Indonesia. We used a mixed-methods approach combining a stakeholder consultation in Jakarta (13\/03\/2025) among 28 participants with diverse expertise and follow-up interviews with two of those participants. Participants completed a structured questionnaire (via Slido) consisting of closed- and open-ended questions, adapted into Bahasa. Questions explored factors to be considered regarding vaccine introduction, target populations, delivery strategies, regulatory considerations, and lessons from other vaccine programs. Quantitative data were analysed descriptively, and qualitative responses underwent thematic analysis. All participants agreed on the importance of TB vaccine introduction. Key concerns were minimum efficacy of 50% and comparative effectiveness against other interventions, such as TB preventive treatment. Most agreed that vaccine introduction should not depend on local manufacturing capacity, administration route, or dosage. Critical enablers identified were adequate funding, strong political commitment, and demand generation through public acceptance. Priority target populations included people living with HIV\/AIDS, individuals with diabetes, household contacts of TB patients, adolescents, and healthcare workers. Major challenges highlighted were vaccine hesitancy, halal issues, misinformation, and limited healthcare worker knowledge. Opinions diverged regarding the feasibility of vaccine rollout without Interferon-Gamma Release Assay (IGRA) testing: nine opposed vaccinating those with IGRA-negative status, six abstained, and three argued that IGRA-testing was unnecessary and cost-inefficient due to its high price. Regulatory and budgeting processes were cited as additional barriers. Introducing new TB vaccines in Indonesia will be complex and concerns extend beyond efficacy. Its success will depend on coordinated strategies to define target populations, design tailored delivery approaches, address vaccine hesitancy, and navigate regulatory and financing challenges.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005537","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:01:39Z","timestamp":1783015299000},"page":"e0005537","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["How can new TB vaccines be effectively introduced in Indonesia? Insights from diverse stakeholders"],"prefix":"10.1371","volume":"6","author":[{"given":"Nina Dwi","family":"Putri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-0524","authenticated-orcid":true,"given":"Ahmad","family":"Fuady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nugroho","family":"Soeharno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-2359","authenticated-orcid":true,"given":"Aqila Sakina","family":"Zafira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta Sirena","family":"Valeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratama","family":"Wicaksana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-3584","authenticated-orcid":true,"given":"Poppy","family":"Yuniar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardiati","family":"Nadjib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhiim","family":"Yudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-0728","authenticated-orcid":true,"given":"Katherine A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-0301","authenticated-orcid":true,"given":"Rebecca A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Rezeki","family":"Hadinegoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"pgph.0005537.ref001","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"issue":"9","key":"pgph.0005537.ref002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cmi.2023.10.023","article-title":"Tuberculosis prevention: current strategies and future directions","volume":"30","author":"A Vasiliu","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"pgph.0005537.ref003","unstructured":"World Health Organization. WHO preferred product characteristics for new tuberculosis vaccines. Geneva: World Health Organization; 2018."},{"key":"pgph.0005537.ref004","volume-title":"An investment case for new tuberculosis vaccines","author":"World Health Organization","year":"2022","edition":"1"},{"issue":"1","key":"pgph.0005537.ref005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S2213-2600(23)00409-5","article-title":"The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis","volume":"12","author":"KA Millington","year":"2024","journal-title":"Lancet Respir Med"},{"key":"pgph.0005537.ref006","unstructured":"United Nations. UN general assembly high-level meeting on the fight against tuberculosis. United Nations; 2023."},{"key":"pgph.0005537.ref007","unstructured":"United Nations. Political declaration of the high-level meeting on the fight against tuberculosis. New York: United Nations; 2023."},{"issue":"1","key":"pgph.0005537.ref008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/imr.12965","article-title":"BCG-induced protection against Mycobacterium tuberculosis infection: evidence, mechanisms, and implications for next-generation vaccines","volume":"301","author":"M Foster","year":"2021","journal-title":"Immunol Rev"},{"key":"pgph.0005537.ref009","doi-asserted-by":"crossref","first-page":"100595","DOI":"10.1016\/j.ijregi.2025.100595","article-title":"The critical role of new tuberculosis vaccines in achieving the WHO 2035 End TB target","volume":"14","author":"AA Maani","year":"2025","journal-title":"IJID Reg"},{"key":"pgph.0005537.ref010","unstructured":"Stop TB Partnership. TB vaccine clinical pipeline. 2026. Available from: https:\/\/newtbvaccines.org\/tb-vaccine-pipeline\/clinical-phase\/. Accessed 30 May 2025."},{"issue":"25","key":"pgph.0005537.ref011","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final Analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"DR Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"pgph.0005537.ref012","volume-title":"WHO global framework to prepare for country introduction of new TB vaccines for adults and adolescents","author":"World HealthOrganization","year":"2025","edition":"1"},{"issue":"8","key":"pgph.0005537.ref013","article-title":"Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach","volume":"5","author":"MM Gill","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"pgph.0005537.ref014","doi-asserted-by":"crossref","first-page":"127490","DOI":"10.1016\/j.vaccine.2025.127490","article-title":"New adult and adolescent tuberculosis vaccines and Indonesia: policy planning and evidence, November 2024","volume":"62","author":"M Alfaqeeh","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"pgph.0005537.ref015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40900-023-00433-6","article-title":"Key issues for stakeholder engagement in the development of health and healthcare guidelines","volume":"9","author":"J Petkovic","year":"2023","journal-title":"Res Involv Engagem"},{"issue":"8","key":"pgph.0005537.ref016","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2019-000582","article-title":"Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs","volume":"29","author":"R Murillo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"pgph.0005537.ref017","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa2412381","article-title":"BCG revaccination for the prevention of Mycobacterium tuberculosis infection","volume":"392","author":"AC Schmidt","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"pgph.0005537.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236743","article-title":"Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India","volume":"15","author":"M Paradkar","year":"2020","journal-title":"PLoS One"},{"key":"pgph.0005537.ref019","volume-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment; Module 1: Prevention","author":"World Health Organization","year":"2024","edition":"2"},{"issue":"12","key":"pgph.0005537.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003435","article-title":"Antenatal corticosteroid administration and early school age child development: a regression discontinuity study in British Columbia, Canada","volume":"17","author":"JA Hutcheon","year":"2020","journal-title":"PLoS Med"},{"issue":"43","key":"pgph.0005537.ref021","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"GM Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pgph.0005537.ref022","unstructured":"Ministry of Health Republic of Indonesia. Program Penanggulangan Tuberkulosis di Indonesia; 2025."},{"issue":"22","key":"pgph.0005537.ref023","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"H Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"pgph.0005537.ref024","article-title":"Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases","volume":"8","author":"W Mao","year":"2023","journal-title":"BMJ Glob Health"},{"key":"pgph.0005537.ref025","author":"S Palmer","year":"2024"},{"key":"pgph.0005537.ref026","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007\u20132012","volume":"32","author":"HJ Larson","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"pgph.0005537.ref027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005347","article-title":"COVID-19 vaccines pricing policy options for low-income and middle- income countries","volume":"6","author":"J Guzman","year":"2021","journal-title":"BMJ Glob Health"},{"key":"pgph.0005537.ref028","article-title":"Vaccine distribution and delivery","volume-title":"Globally resilient supply chains for seasonal and pandemic influenza vaccines","author":"National Academy of Medicine","year":"2021"},{"key":"pgph.0005537.ref029","unstructured":"Vaccine Alliance. Breaking down the real costs of vaccine delivery; 2025. Available from: https:\/\/www.vaccinealliance.org\/site-repository\/resource\/7_02_ifresources\/"},{"issue":"35","key":"pgph.0005537.ref030","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.vaccine.2021.06.076","article-title":"Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic","volume":"39","author":"C Banks","year":"2021","journal-title":"Vaccine"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:01:58Z","timestamp":1783015318000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005537"}},"subtitle":[],"editor":[{"given":"Suman","family":"Majumdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005537","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}